Page last updated: 2024-11-02

oxyphenbutazone and Corneal Opacity

oxyphenbutazone has been researched along with Corneal Opacity in 2 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Norn, MS1
Watson, PG1
Hayreh, SS1
Awdry, PN1

Other Studies

2 other studies available for oxyphenbutazone and Corneal Opacity

ArticleYear
Dendritic (herpetic) keratitis. II. Follow-up examination of corneal opacity. (Opacity, vascularisation, Hudson-Stähli's line, sequelae of iritis).
    Acta ophthalmologica, 1970, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Aged; Cautery; Child; Child, Preschool; Cornea; Corneal Opacity; Corneal Transpla

1970
Episcleritis and scleritis. II.
    The British journal of ophthalmology, 1968, Volume: 52, Issue:4

    Topics: Corneal Opacity; Eye Diseases; Humans; Indomethacin; Inflammation; Keratitis; Oxyphenbutazone; Predn

1968